首页 > 市场调查报告书 > 製药

生物製剂

市场调查报告书

商品编码

1707297

全球细胞膜穿透胜肽市场按类型、应用、最终用户和地区划分

Global Cell Penetrating Peptide Market, By Type, By Application, By End User, By Geography

出版日期: 2025年03月04日 | 出版商:

Coherent Market Insights | 英文 179 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计 2025 年全球细胞膜穿透胜肽市场规模为 42 亿美元，到 2032 年将达到 121.6 亿美元，2025 年至 2032 年的复合年增长率为 16.4%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	42亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	16.40%	2032年价值预测	121.6亿美元

数字。 2025年全球市场占有率（%）

细胞穿透胜肽（CPP）是一类短胺基酸序列，可穿过细胞膜并将抗体、核酸和化疗药物等生物活性剂输送到细胞中。其跨越屏障的能力使其成为一种重要的分子转运体，能够输送多种临床实验和核准的治疗剂。在这个市场中，正在积极进行研究，优化细胞穿透胜肽（CPP）的序列和结合技术，以改善稳定性、溶解度和细胞吸收效率等药理特性。随着人们对开发基于 CPP 的癌症、神经退化和慢性感染疾病等疾病的市场策略的兴趣日益浓厚，细胞穿透胜肽市场预计将在未来几年快速增长。

CPPs 与传统转染方法相比具有许多优势，因为它们可以在生理条件下非侵入性、高效、快速地将货物分子输送到活细胞中。由于其易于分子结合和高度生物相容性，CPP 在研究和治疗应用方面具有巨大潜力，包括蛋白质治疗、基因传递和诊断成像。然而，其非选择性双层破坏和高浓度下的潜在细胞毒性仍然是主要挑战。改进的设计策略旨在开发更安全、更特异性的CPP。

市场动态：

细胞膜穿透胜肽市场的发展受到以下因素的推动：癌症等需要细胞内输送治疗剂的疾病数量的增加、研发的进步、製药公司的投资以及胜肽类药物的日益普及。然而，一些CPPs存在的稳定性差、毒性不可预测、免疫反应抑制等问题阻碍了市场的成长。正在进行的开发新一代无毒且高度生物相容性的胜肽序列的研究提供了巨大的商业机会。

本研究的主要特点

本报告对全球细胞膜穿透胜肽市场进行了详细分析，并提供了预测期（2025-2032）的市场规模和年复合成长率（CAGR%），以 2024 年为基准年。
它还强调了各个领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
它根据公司亮点、产品系列、关键亮点、绩效和策略等参数，介绍了全球细胞膜穿透胜肽市场的主要企业概况。
本报告的见解将使负责人和企业经营团队能够就未来的产品发布、高端市场策略、市场扩张和行销策略做出明智的决策。
本研究报告针对该产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过分析全球细胞膜穿透胜肽市场所使用的各种策略矩阵来促进他们的决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 4.2 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	16.40%	2032 Value Projection:	USD 12.16 Bn

Cell penetrating peptides (CPPs) are short sequences of amino acids that are able to cross cell membranes and deliver attached bioactive cargo such as antibodies, nucleic acids, and chemotherapeutics into cells. Their ability to traverse barriers has made them important molecular transporters, enabling the delivery of various investigational and approved therapeutics. The market has witnessed considerable research on optimizing Cell penetrating peptides (CPPs) sequences and conjugation techniques to improve pharmacological properties such as stability, solubility, and cellular uptake efficiency. With growing interest in developing CPP-based delivery strategies for diseases like cancer, neurodegeneration, and chronic infections, the cell penetrating peptide market is anticipated to grow at a rapid pace in the future.

CPPs offer numerous advantages over traditional transfection methods as they provide a non-invasive, efficient, and rapid delivery of cargo molecules into live cells under physiological conditions. Given their easy molecular conjugation and biocompatible uptake, CPPs hold immense potential for research and therapeutic applications including protein therapy, gene delivery, and diagnostic imaging. However, their non-selective bilayer disruption and possible cytotoxicity at higher concentrations remain major challenges. Improved design strategies aim to develop safer and more target-specific CPPs.

Market Dynamics:

The cell penetrating peptide market is driven by rising incidences of diseases such as cancer and others requiring intracellular delivery of therapeutics, increasing research and development, investments by pharmaceutical companies, and growing adoption of peptide-based drugs. However, challenges pertaining to poor stability, unpredictable toxicity, and immune response inhibition associated with some CPPs hamper market growth. Ongoing research to engineer newer generations of non-toxic and biocompatible peptide sequences presents significant opportunities.

Key features of the study:

This report provides in-depth analysis of the global cell penetrating peptide market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cell penetrating peptide market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include AnaSpec, Peptomyc, BioAlps, Sarepta Therapeutics, Inc., REVANCE THERAPEUTICS, PolyPeptide Group, Bachem, Pepscan Creative Peptides, Cupidpeptides and AltaBioscience Ltd
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global cell penetrating peptide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell penetrating peptide market

Detailed Segmentation:

Global Cell Penetrating Peptide Market, By Type
- Protein Derived CPPs
- Synthetic CPPs
- Chimeric CPPs
Global Cell Penetrating Peptide Market, By Application
- Drug Delivery
- Gene Delivery
- Diagnostics
- Molecular Imaging
- Others
Global Cell Penetrating Peptide Market, By End User
- Biopharmaceutical Companies
- Contract Research Organization (CROs)/CDMO
- Hospitals and Clinics
- Others
Global Cell Penetrating Peptide Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Company Profiles
- AnaSpec
- Peptomyc
- BioAlps
- Sarepta Therapeutics, Inc.
- REVANCE THERAPEUTICS
- PolyPeptide Group
- Bachem
- Pepscan
- Creative Peptides
- Cupidpeptides
- AltaBioscience Ltd

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Cell Penetrating Peptide Market, By Type
- Global Cell Penetrating Peptide Market, By Application
- Global Cell Penetrating Peptide Market, By End User
- Global Cell Penetrating Peptide Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Expanding Applications in Regenerative Medicine
- Low drug encapsulation efficiency
- Increasing applications of CPPs in therapeutics development
Impact Analysis
Key Highlights
Regulatory Scenario
Service offering Portfolio
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Pipeline Analysis

4. Global Cell Penetrating Peptide Market- Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Cell Penetrating Peptide Market, By Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Protein Derived CPPs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Synthetic CPPs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Chimeric CPPs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Cell Penetrating Peptide Market, By Application, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Drug Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Gene Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Molecular Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Cell Penetrating Peptide Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Contract Research Organization (CROs)/CDMO
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Cell Penetrating Peptide Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

AnaSpec
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Peptomyc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
BioAlps
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sarepta Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
REVANCE THERAPEUTICS
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
PolyPeptide Group
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Strategies
Bachem
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pepscan
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Creative Peptides
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Cupidpeptides
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AltaBioscience Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

10. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

全球细胞膜穿透胜肽市场按类型、应用、最终用户和地区划分